Table 3.
Overview of instruments with associated assessment points
| Measure (instrument) | Assessment point | |||||
|---|---|---|---|---|---|---|
| T0 | T1 | T2 | T3 | T4 | T5 | |
| Screening | ||||||
| Depression (CES-D) | X | |||||
| Anxiety (GAD-7) | X | X | X | X | X | |
| Demographic data | X | |||||
| Mental disorder diagnosis self-reported | X | |||||
| Experience with psychotherapy | X | |||||
| Clinical diagnosis (M.I.N.I.) | X | X | X | |||
| Primary outcomes | ||||||
| Depression (QIDS) | X | X | X | X | ||
| Anxiety (SIGH-A) | X | X | X | X | ||
| Secondary outcomes | ||||||
| Depression (PHQ-9) | X | X | X | X | X | |
| Anxiety (GAD-7) | X | X | X | X | X | |
| Clinical diagnosis (M.I.N.I.) | X | X | X | |||
| Academic performance (PSS, ECTS) | X | X | X | X | X | |
| Cost-effectiveness | ||||||
| Costs (CSRI) | X | X | X | |||
| Other outcomes | ||||||
| Alcohol use (AUDIT-C) | X | X | X | X | X | |
| Alliance (WAI-SR)a | X | |||||
| Behavioral activation (BADS-SF) | X | X | X | X | ||
| Reasons for dropouta | X | |||||
| Expectations (CEQ) | X | |||||
| Incongruence (INKK) | X | X | X | X | ||
| Motivation (TEQ) | X | X | X | |||
| Negative effects of treatment (INEP)a | X | |||||
| Personality (BFI-10) | X | |||||
| Potential risk factorsb | X | |||||
| Program evaluation (CSQ-8)a | X | X | ||||
| Quality of life (AQoL, EQ-5D-8 L) | X | X | X | X | ||
| Resilience (CD-RISC) | X | X | X | X | X | |
| Sleep quality (PSQI) | X | X | X | X | ||
| Supporta | X | |||||
| Wellbeing (WHO-5) | X | X | X | X | ||
| Worry (PSWQ-3) | X | X | X | X | ||
aOnly in intervention groups
bOptional
T0 screening, T1 baseline, T2 after completion of session 5 or 5 weeks after randomization, T3 post intervention, T4 6-month follow-up, T5 12-month follow-up